NEO (NeoGenomics) Days Payable : 18.20 (As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is NeoGenomics Days Payable?

NeoGenomics's average Accounts Payable for the three months ended in Mar. 2025 was $18.9 Mil. NeoGenomics's Cost of Goods Sold for the three months ended in Mar. 2025 was $94.8 Mil. Hence, NeoGenomics's Days Payable for the three months ended in Mar. 2025 was 18.20.

The historical rank and industry rank for NeoGenomics's Days Payable or its related term are showing as below:

NEO' s Days Payable Range Over the Past 10 Years
Min: 17.52 Med: 31.79 Max: 61.08
Current: 17.52

During the past 13 years, NeoGenomics's highest Days Payable was 61.08. The lowest was 17.52. And the median was 31.79.

NEO's Days Payable is ranked worse than
90.63% of 192 companies
in the Medical Diagnostics & Research industry
Industry Median: 59.915 vs NEO: 17.52

NeoGenomics's Days Payable declined from Mar. 2024 (19.44) to Mar. 2025 (18.20). It may suggest that NeoGenomics accelerated paying its suppliers.

NeoGenomics Days Payable Historical Data

The historical data trend for NeoGenomics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoGenomics Days Payable Chart

NeoGenomics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

31.43

26.33

21.79

21.48

20.66

NeoGenomics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Payable	Get a 7-Day Free Trial															19.44	17.61	16.54	18.36	18.20

Competitive Comparison of NeoGenomics's Days Payable

For the Diagnostics & Research subindustry, NeoGenomics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeoGenomics's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NeoGenomics's Days Payable distribution charts can be found below:

* The bar in red indicates where NeoGenomics's Days Payable falls into.

Save Embed

;

Save Embed

;

NeoGenomics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

NeoGenomics's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (20.334	+	21.607)	/	2 )	/	370.466	*	365
=	20.9705					/	370.466	*	365
=	20.66

NeoGenomics's Days Payable for the quarter that ended in Mar. 2025 is calculated as:

	Days Payable (Q: Mar. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2024 )	+	Accounts Payable (Q: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2025 )	*	Days in Period
=	( (21.607	+	16.211)	/	2 )	/	94.789	*	365 / 4
=	18.909					/	94.789	*	365 / 4
=	18.20

NeoGenomics Days Payable Related Terms

Thank you for viewing the detailed overview of NeoGenomics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoGenomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NeoGenomics Inc (NAS:NEO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

NG9:Germany

Address

9490 NeoGenomics Way, Fort Myers, FL, USA, 33912

Website

https://www.neogenomics.com

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Executives

Michael Aaron Kelly	director	C/O HOOKIPA PHARMA INC., 430 EAST 29TH ST., NEW YORK NY 10016
Warren Stone	officer: President, Clinical Services	9490 NEOGENOMICS WAY, FORT MYERS FL 33912
Lynn A. Tetrault	director	12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913
Stephen M Kanovsky	director	88 OLD YORK ROAD, NEW HOPE PA 18938
Anthony P. Zook	director	C/O VIVUS, INC., 351 EAST EVELYN AVENUE, MOUNTAIN VIEW CA 94041
David Brian Perez	director	12100 6TH AVENUE, LAKEWOOD CO 80228
Neil Gunn	director	9490 NEOGENOMICS WAY, FORT MYERS FL 33912
Jeffrey Scott Sherman	officer: Chief Financial Officer	103 POWELL COURT, SUITE 200, BRENTWOOD TN 37027
Alicia C Olivo	officer: General Counsel	9490 NEOGENOMICS WAY, FORT MYERS FL 33912
Elizabeth Floegel	director	9490 NEOGENOMICS WAY, FORT MYERS FL 33912
Greg D Aunan	officer: Chief Accounting Officer	HMS HOLDINGS CORP., 5615 HIGH POINT DRIVE, IRVING TX 75038
Melody Harris	officer: President, Enterprise Ops	4801 WEST BYRON PLACE, DENVER CO 80211
Christopher M Smith	officer: Chief Executive Officer	125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Shashikant Kulkarni	officer: President of Lab Operations	9490 NEOGENOMICS WAY, FORT MYERS FL 33912
Vishal Sikri	officer: President and CCO, Inivata	9490 NEOGENOMICS WAY, FORT MYERS FL 33912